Population pharmacokinetics of imatinib mesylate in patients with chronic-phase chronic myeloid leukaemia: Results of a phase III study Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Agents
  • Leukemia, Myeloid, Chronic-Phase
  • Piperazines
  • Pyrimidines

abstract

  • Population covariates and coadministered drugs minimally affected imatinib pharmacokinetics in newly diagnosed CP CML patients.

publication date

  • July 2005

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC1884912

Digital Object Identifier (DOI)

  • 10.1111/j.1365-2125.2005.02372.x

PubMed ID

  • 15963092

Additional Document Info

start page

  • 35

end page

  • 44

volume

  • 60

number

  • 1